Lesson plan

Adrenergic blocking agent

Adrenergic blocking agents are a class of drugs that exhibit its pharmacological action through inhibiting the action of the sympathetic nervous system (SNS) in the body. The sympathetic nervous system is an autonomic nervous system that we cannot control by will. It triggers a series of responses after the body releases chemicals named noradrenaline (norepinephrine) and adrenaline (epinephrine). These chemicals will act on adrenergic receptors, with subtypes alpha-1, alpha-2, beta-1, beta-2, and beta-3, which ultimately allow the body to trigger a fight-or-flight response to handle external stress. These responses include vessel constriction in general vessels whereas there is vasodilation in vessels that supply skeletal muscles or in coronary vessels. Additionally, heart rate and contractile force increases when the SNS is activated, which may be harmful to cardiac function as it increases metabolic demand. Adrenergic blocking agents treat certain diseases through blocking the adrenergic receptor, preventing it from being activated by noradrenaline and adrenaline. As a result, it stops the body from producing the fight-or-flight response.

Back to article

Article summary

Adrenergic blocking agents are a class of drugs that exhibit its pharmacological action through inhibiting the action of the sympathetic nervous system (SNS) in the body. The sympathetic nervous system is an autonomic nervous system that we cannot control by will. It triggers a series of responses after the body releases chemicals named noradrenaline (norepinephrine) and adrenaline (epinephrine). These chemicals will act on adrenergic receptors, with subtypes alpha-1, alpha-2, beta-1, beta-2, and beta-3, which ultimately allow the body to trigger a fight-or-flight response to handle external stress. These responses include vessel constriction in general vessels whereas there is vasodilation in vessels that supply skeletal muscles or in coronary vessels. Additionally, heart rate and contractile force increases when the SNS is activated, which may be harmful to cardiac function as it increases metabolic demand. Adrenergic blocking agents treat certain diseases through blocking the adrenergic receptor, preventing it from being activated by noradrenaline and adrenaline. As a result, it stops the body from producing the fight-or-flight response.

Key claims

No claims recorded.

Discussion questions

  1. Summarise the article in your own words. Which single claim would you verify first, and why?
  2. Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
  3. If two sources disagreed about one of these facts, what would you need in order to trust one over the other?

Bibliography

No sources recorded.

Key claims and bibliography are generated from the same tracked claims and sources as the article page.